<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:05:29Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/28338" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/28338</identifier><datestamp>2026-09-24T18:31:49Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Wright, Gerard D</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Guitor, Allison Kate</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biochemistry and Biomedical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2023-02-27T18:42:13Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2023-02-27T18:42:13Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2023</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/28338</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/17918</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Antibiotic-resistant bacteria and their often-untreatable infections are increasing globally. &#xd;
The determinants that confer reduced susceptibility to antibiotics are encoded in the genetic &#xd;
information, or genes, of bacteria. Sequencing-based approaches to identify antibiotic &#xd;
resistance genes (ARGs) in diverse environments, such as the gut microbiome, are limited &#xd;
in throughput and inaccessible due to high costs. The microbiome and its associated ARGs &#xd;
are shaped by many factors throughout early life, which have yet to be fully characterized. &#xd;
In this thesis, I developed an approach to capture ARGs in the gut microbiome and study &#xd;
the effect of various early-life exposures. &#xd;
First, I describe a set of over 37,000 probes to target over 2,000 ARGs. This targeted &#xd;
sequencing approach was designed and validated against samples of DNA isolated from &#xd;
multi-drug resistant bacteria. This probeset proved superior to metagenomic shotgun &#xd;
sequencing in capturing the rare portion of ARGs from a human gut microbiome sample. Second, I investigated the potential benefits of providing probiotics to infants born preterm&#xd;
 in reducing antibiotic resistance in their gut microbiomes. Preterm infants that received &#xd;
probiotics had a reduced burden of ARGs associated with potentially pathogenic bacteria &#xd;
at 5 months of age compared to non-probiotic-supplemented preterm infants. &#xd;
Finally, I explored the potential consequences of macrolide antibiotic exposure on ARGs &#xd;
in the gut microbiome of children with diarrhoea in Botswana, Africa. Compared to the &#xd;
standard treatment for diarrhoea, a three-day dose of azithromycin did not result in an &#xd;
increased selection for ARGs after 60 days. &#xd;
This thesis tackles the challenge of comprehensively detecting antibiotic resistance in the &#xd;
gut microbiome. A better understanding of the impact of early-life exposures, including &#xd;
probiotic and antibiotic treatments, in the prevention or maintenance of ARGs in the gut &#xd;
microbiome of children will help reduce unnecessary selective pressures and the &#xd;
persistence of antibiotic resistance into later life.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">Infection rates associated with antibiotic-resistant bacteria are increasing. The traits that &#xd;
allow bacteria to survive antibiotics are encoded by their genetic information or genes.&#xd;
 There is a wide diversity of antibiotic resistance mechanisms available to bacteria and &#xd;
comprehensive methods to detect them are needed. My work presents the development and &#xd;
validation of an approach to capture and sequence all known antibiotic resistance genes. &#xd;
With this tool, I investigated the early life exposures that shape antibiotic resistance in the &#xd;
diverse community of bacteria encompassing the human gut microbiome. First, I revealed&#xd;
 the protective effects of providing beneficial bacteria, or probiotics, to preterm infants. &#xd;
Next, I uncovered a minimal impact of antibiotic treatment in selecting for antibiotic &#xd;
resistance genes in children with diarrhoea. Improved tools to understand antibiotic &#xd;
resistance in early-life and the factors that modulate its prevalence will help reduce the&#xd;
persistence of antibiotic-resistant bacteria in later life.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Antibiotic resistance</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Microbiome</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Probiotics</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Preterm infants</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Antibiotics</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Next-generation sequencing</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Capturing Antibiotic Resistance Genes in the Human Gut Microbiome After Probiotic and Antibiotic Exposures</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative" lang="en_US">FACTORS IMPACTING ANTIBIOTIC RESISTANCE IN THE MICROBIOME</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>